Clinical Trial Update: Metformin in Co-morbid Diabetes or Prediabetes and Serious Mental Illness [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating metformin in individuals with type 2 diabetes or prediabetes and schizophrenia has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prediabetes
• Schizophrenia
• Type 2 Diabetes Mellitus

Drugs mentioned

• metformin (metformin)

Snippet

Sponsor: Centre for Addiction and Mental Health | Conditions: Diabetes Mellitus, Type 2, Schizophrenia | Phase 4 | Status: COMPLETED